Back
78
Also listed as
TKPHF
OTC
Day Range
$18.23
$18.39
52-Week Range
$12.99
$18.82
Volume
2,561,473
50D / 200D Avg
$17.61
/
$15.40
Prev Close
$18.04
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.5 | 0.2 |
| P/B | 0.0 | 3.0 |
| ROE % | 1.5 | 3.6 |
| Net Margin % | 2.4 | 3.8 |
| Rev Growth 5Y % | 9.4 | 9.9 |
| D/E | 0.7 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$162.65
$156.76 – $166.23
|
5.01T | 1 |
| FY2029 |
$133.38
$128.55 – $136.31
|
4.86T | 1 |
| FY2028 |
$106.60
$102.74 – $108.95
|
4.74T | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-01-29 | $0.14 | $0.48 | +251.9% |
| 2025-10-30 | $0.44 | $0.44 | 0.0% |
| 2025-07-30 | $0.47 | $0.52 | +10.6% |
| 2025-06-25 | N/A | -$0.22 | — |
| 2025-01-30 | $0.63 | $0.42 | -33.3% |
| 2024-10-31 | $0.39 | $0.44 | +12.8% |
| 2024-07-31 | $0.37 | $0.56 | +51.4% |
| 2024-05-09 | $0.00 | -$0.01 | -330.5% |
Insider Trading Activity
8 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 28, 2026 |
Lo Andrew Tak Shing
Senior Managing Director
|
grant | 227,637 | — | — |
| Feb 28, 2026 |
Lo Andrew Tak Shing
Senior Managing Director
|
other | 66,848 | — | — |
| Feb 2, 2026 |
Wu Ping Tak
VP, U.S. Operations
|
grant | 15,000 | — | — |
| Jan 26, 2026 |
Tak Paul Peter
Chief Executive Officer
|
grant | 629,000 | — | — |
| Aug 4, 2025 |
Wu Ping Tak
VP, U.S. Operations
|
grant | 30,000 | — | — |
| Jun 25, 2025 |
Tak Paul Peter
Chief Executive Officer
|
grant | 42,826 | $4.67 | $199,997.42 |
| Jun 24, 2025 |
YU Wing Tak Wendy
Director
|
grant | 20,000 | — | — |
| May 5, 2025 |
Wu Ping Tak
VP, U.S. Operations
|
grant | 15,000 | — | — |
Dividend History
7 yr streakYield
0.04%
Payout Ratio
2.80%
Growth (3Y)
-3.25%
Growth (5Y)
-6.80%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Sep 30, 2025 | Dec 11, 2025 | $0.32 | 4.08% |
| Mar 31, 2025 | Jul 07, 2025 | $0.28 | 4.05% |
| Sep 30, 2024 | Dec 12, 2024 | $0.33 | 4.35% |
| Mar 27, 2024 | Jul 08, 2024 | $0.29 | 4.31% |
| Sep 28, 2023 | Dec 11, 2023 | $0.32 | 4.03% |
| Mar 30, 2023 | Jul 10, 2023 | $0.31 | 3.91% |
| Sep 29, 2022 | Dec 12, 2022 | $0.33 | 5.09% |
| Mar 30, 2022 | Jul 11, 2022 | $0.33 | 5.04% |
| Sep 29, 2021 | Dec 13, 2021 | $0.40 | 4.93% |
| Mar 30, 2021 | Jul 12, 2021 | $0.41 | 4.56% |
| Sep 29, 2020 | Dec 11, 2020 | $0.43 | 4.68% |
| Mar 30, 2020 | Jul 06, 2020 | $0.42 | 5.31% |
| Sep 27, 2019 | Dec 12, 2019 | $0.41 | 4.42% |
| Mar 27, 2019 | Jun 28, 2019 | $0.36 | 3.53% |
| Sep 26, 2018 | Dec 13, 2018 | $0.40 | 3.70% |
| Mar 27, 2018 | Jul 09, 2018 | $0.41 | 3.06% |
| Sep 27, 2017 | Dec 11, 2017 | $0.40 | 2.89% |
| Mar 29, 2017 | Jul 10, 2017 | $0.40 | 3.42% |
| Sep 29, 2016 | Dec 12, 2016 | $0.39 | 3.48% |
| Mar 30, 2016 | Jul 11, 2016 | $0.44 | 3.43% |
Key Takeaways
Revenue grew 9.41% annually over 5 years — modest growth
Earnings declined -25.08% over the past year
ROE of 1.52% is below average
Generating 856.39B in free cash flow
P/E of 0.54 — trading at a low valuation
Cash machine — converts 793.48% of earnings into free cash flow
Growth
Revenue Growth (5Y)
9.41%
Revenue (1Y)7.45%
Earnings (1Y)-25.08%
FCF Growth (3Y)57.90%
Quality
Return on Equity
1.52%
ROIC2.24%
Net Margin2.36%
Op. Margin7.48%
Safety
Debt / Equity
0.65
Current Ratio1.01
Interest Coverage2.50
Valuation
P/E Ratio
0.54
Forward P/E0.32
P/B Ratio0.01
EV/EBITDA12.22
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7.45% | Revenue Growth (3Y) | 6.66% |
| Earnings Growth (1Y) | -25.08% | Earnings Growth (3Y) | -41.65% |
| Revenue Growth (5Y) | 9.41% | Earnings Growth (5Y) | -26.80% |
| Profitability | |||
| Revenue (TTM) | 4.58T | Net Income (TTM) | 107.93B |
| ROE | 1.52% | ROA | 0.76% |
| Gross Margin | 65.51% | Operating Margin | 7.48% |
| Net Margin | 2.36% | Free Cash Flow (TTM) | 856.39B |
| ROIC | 2.24% | FCF Growth (3Y) | 57.90% |
| Safety | |||
| Debt / Equity | 0.65 | Current Ratio | 1.01 |
| Interest Coverage | 2.50 | ||
| Dividends | |||
| Dividend Yield | 0.04% | Payout Ratio | 2.80% |
| Dividend Growth (3Y) | -3.25% | Dividend Growth (5Y) | -6.80% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 0.54 | Forward P/E | 0.32 |
| P/B Ratio | 0.01 | P/S Ratio | 0.01 |
| PEG Ratio | -2.57 | Forward PEG | N/A |
| EV/EBITDA | 12.22 | Fwd EV/EBITDA | 3.03 |
| Forward P/S | 0.01 | Fwd Earnings Yield | 312.50% |
| FCF Yield | 1482.11% | ||
| Market Cap | 57.78B | Enterprise Value | 4.19T |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 4.58T | 4.26T | 4.03T | 3.57T | 3.20T |
| Net Income | 107.93B | 144.07B | 317.02B | 230.06B | 376.01B |
| EPS (Diluted) | 33.62 | 45.58 | 100.97 | 72.94 | 119.48 |
| Gross Profit | 3.00T | 2.83T | 2.78T | 2.46T | 2.20T |
| Operating Income | 342.59B | 214.08B | 490.51B | 460.84B | 509.27B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 14.25T | 15.11T | 13.96T | 13.18T | 12.91T |
| Total Liabilities | 7.31T | 7.83T | 7.60T | 7.49T | 7.74T |
| Shareholders' Equity | 6.94T | 7.27T | 6.35T | 5.68T | 5.17T |
| Total Debt | 4.52T | 4.84T | 4.38T | 4.35T | 4.64T |
| Cash & Equivalents | 385.11B | 457.80B | 533.53B | 849.70B | 966.22B |
| Current Assets | 2.52T | 2.56T | 2.40T | 2.59T | 2.71T |
| Current Liabilities | 2.51T | 2.31T | 2.48T | 2.15T | 1.77T |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#48 of 1049
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026